150 related articles for article (PubMed ID: 36457227)
21. Unique molecular signatures typify skin inflammation induced by chemical allergens and irritants.
Lefevre MA; Nosbaum A; Rozieres A; Lenief V; Mosnier A; Cortial A; Prieux M; De Bernard S; Nourikyan J; Jouve PE; Buffat L; Hacard F; Ferrier-Lebouedec MC; Pralong P; Dzviga C; Herman A; Baeck M; Nicolas JF; Vocanson M
Allergy; 2021 Dec; 76(12):3697-3712. PubMed ID: 34174113
[TBL] [Abstract][Full Text] [Related]
22. Skin irritants and contact sensitizers induce Langerhans cell migration and maturation at irritant concentration.
Jacobs JJ; Lehé CL; Hasegawa H; Elliott GR; Das PK
Exp Dermatol; 2006 Jun; 15(6):432-40. PubMed ID: 16689859
[TBL] [Abstract][Full Text] [Related]
23. Establishment and evaluation of immortalized human epidermal keratinocytes for an alternative skin irritation test.
Kim CW; Kim CD; Choi KC
J Pharmacol Toxicol Methods; 2017; 88(Pt 2):130-139. PubMed ID: 28827132
[TBL] [Abstract][Full Text] [Related]
24. A study of skin responses to follow-up, rechallenge and combined effects of irritants using non-invasive measurements.
Park KB; Eun HC
J Dermatol Sci; 1995 Sep; 10(2):159-65. PubMed ID: 8534615
[TBL] [Abstract][Full Text] [Related]
25. In vitro and human testing strategies for skin irritation.
Robinson MK; Osborne R; Perkins MA
Ann N Y Acad Sci; 2000; 919():192-204. PubMed ID: 11083109
[TBL] [Abstract][Full Text] [Related]
26. Further development of the NCTC 2544 IL-18 assay to identify in vitro contact allergens.
Galbiati V; Mitjans M; Lucchi L; Viviani B; Galli CL; Marinovich M; Corsini E
Toxicol In Vitro; 2011 Apr; 25(3):724-32. PubMed ID: 21182927
[TBL] [Abstract][Full Text] [Related]
27. The mechanism of retinol-induced irritation and its application to anti-irritant development.
Kim BH; Lee YS; Kang KS
Toxicol Lett; 2003 Dec; 146(1):65-73. PubMed ID: 14615068
[TBL] [Abstract][Full Text] [Related]
28. Assessment of contact allergens by dissociation of irritant and sensitizing properties.
Jacobs JJ; Lehé CL; Cammans KD; Das PK; Elliott GR
Toxicol In Vitro; 2004 Oct; 18(5):681-90. PubMed ID: 15251187
[TBL] [Abstract][Full Text] [Related]
29. Release of arachidonic and linoleic acid metabolites in skin organ cultures as characteristics of in vitro skin irritancy.
van de Sandt JJ; Maas WJ; Doornink PC; Rutten AA
Fundam Appl Toxicol; 1995 Apr; 25(1):20-8. PubMed ID: 7601324
[TBL] [Abstract][Full Text] [Related]
30. Activation of neurons in rat trigeminal subnucleus caudalis by different irritant chemicals applied to oral or ocular mucosa.
Carstens E; Kuenzler N; Handwerker HO
J Neurophysiol; 1998 Aug; 80(2):465-92. PubMed ID: 9705444
[TBL] [Abstract][Full Text] [Related]
31. Toxicity of topically applied drugs beyond skin irritation: Static skin model vs. Two organs-on-a-chip.
Tavares RSN; Tao TP; Maschmeyer I; Maria-Engler SS; Schäfer-Korting M; Winter A; Zoschke C; Lauster R; Marx U; Gaspar LR
Int J Pharm; 2020 Nov; 589():119788. PubMed ID: 32882369
[TBL] [Abstract][Full Text] [Related]
32. Intralaboratory validation of alternative endpoints in the murine local lymph node assay for the identification of contact allergic potential: primary ear skin irritation and ear-draining lymph node hyperplasia induced by topical chemicals.
Ulrich P; Streich J; Suter W
Arch Toxicol; 2001 Feb; 74(12):733-44. PubMed ID: 11305775
[TBL] [Abstract][Full Text] [Related]
33. Selective induction of cell-associated interleukin-1alpha in murine keratinocytes by chemical allergens.
Corsini E; Primavera A; Marinovich M; Galli CL
Toxicology; 1998 Aug; 129(2-3):193-200. PubMed ID: 9772097
[TBL] [Abstract][Full Text] [Related]
34. In vitro irritation models and immune reactions.
Gibbs S
Skin Pharmacol Physiol; 2009; 22(2):103-13. PubMed ID: 19188758
[TBL] [Abstract][Full Text] [Related]
35. Development of a flow cytometry assay for the identification and differentiation of chemicals with the potential to elicit irritation, IgE-mediated, or T cell-mediated hypersensitivity responses.
Manetz TS; Meade BJ
Toxicol Sci; 1999 Apr; 48(2):206-17. PubMed ID: 10353312
[TBL] [Abstract][Full Text] [Related]
36. Comparison of in vitro and in vivo human skin responses to consumer products and ingredients with a range of irritancy potential.
Perkins MA; Osborne R; Rana FR; Ghassemi A; Robinson MK
Toxicol Sci; 1999 Apr; 48(2):218-29. PubMed ID: 10353313
[TBL] [Abstract][Full Text] [Related]
37. The prostaglandin E2 receptor, EP2, stimulates keratinocyte proliferation in mouse skin by G protein-dependent and {beta}-arrestin1-dependent signaling pathways.
Chun KS; Lao HC; Langenbach R
J Biol Chem; 2010 Dec; 285(51):39672-81. PubMed ID: 20959465
[TBL] [Abstract][Full Text] [Related]
38. Human Induced Pluripotent Stem Cell-Based Skin for Assessing Transdermal Drug Permeability and Irritancy.
Naito C; Yamaguchi T; Katsumi H; Kimura S; Kamei S; Morishita M; Kawabata K; Yamamoto A
Biol Pharm Bull; 2021; 44(1):140-143. PubMed ID: 33390542
[TBL] [Abstract][Full Text] [Related]
39. MUTZ-3 derived Langerhans cells in human skin equivalents show differential migration and phenotypic plasticity after allergen or irritant exposure.
Kosten IJ; Spiekstra SW; de Gruijl TD; Gibbs S
Toxicol Appl Pharmacol; 2015 Aug; 287(1):35-42. PubMed ID: 26028481
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the skin irritation using a DNA microarray on a reconstructed human epidermal model.
Niwa M; Nagai K; Oike H; Kobori M
Biol Pharm Bull; 2009 Feb; 32(2):203-8. PubMed ID: 19182376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
